Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-006081
Filing Date
2023-02-23
Accepted
2023-02-23 21:56:46
Documents
1
Period of Report
2023-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6433
  Complete submission text file 0000899243-23-006081.txt   8076
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GILEAD SCIENCES 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
WOLD OLSEN PER (Reporting) CIK: 0001181185 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 23662196